Ma Jian, Xue Huan, He Li-Hong, Wang Ling-Yun, Wang Xiao-Juan, Li Xun, Zhang Lei
Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu Province, 730000, People's Republic of China.
Key Laboratory of Biological Therapy and Regenerative Medicine Transformation Gansu Province, Lanzhou, Gansu Province, 730000, People's Republic of China.
Cancer Manag Res. 2021 Nov 2;13:8231-8240. doi: 10.2147/CMAR.S328786. eCollection 2021.
Pancreatic cancer, with high morbidity and mortality rates, is one of the most malignant tumors worldwide. Despite extensive research, the prognosis remains poor. Autophagy, a lysosomal-mediated, highly conserved degradation process that removes abnormal proteins and damaged organelles from the body, is upregulated in pancreatic ductal adenocarcinoma. Based on differences in the tumor microenvironment and tumor stage, the functions of autophagy in the pathophysiology and treatment of pancreatic cancer differ. In the initial phase, autophagy inhibits the transformation of precancerous lesions to cancer. However, in the progressive stage, autophagy promotes tumor growth. Autophagy is also one of the main mechanisms of drug resistance during treatment. Here, we describe the role of autophagy in pancreatic cancer progression and discuss relevant treatment strategies for this disease.
胰腺癌发病率和死亡率都很高,是全球最恶性的肿瘤之一。尽管进行了广泛研究,但其预后仍然很差。自噬是一种由溶酶体介导的、高度保守的降解过程,可清除体内异常蛋白质和受损细胞器,在胰腺导管腺癌中上调。基于肿瘤微环境和肿瘤分期的差异,自噬在胰腺癌病理生理学和治疗中的作用有所不同。在初始阶段,自噬抑制癌前病变向癌症的转变。然而,在进展期,自噬促进肿瘤生长。自噬也是治疗过程中耐药的主要机制之一。在此,我们描述自噬在胰腺癌进展中的作用,并讨论针对该疾病的相关治疗策略。